Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.

NCT06704815•Servier Affaires Médicales

Summary

The primary objective is to assess the change of systolic blood pressure from baseline after a 6-month follow up for hypertensive patients initiating Viacoram® plus an educational program (NGAYDAUTIEN) in comparison to hypertensive patients initiating other antihypertensive drugs (except single pill combination).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Aged of at least 18 years (without upper limit of age)
•2. Diagnosis of grade 1 or grade 2 hypertension
•3. Naïve of treatment:
•* newly diagnosed hypertension and without treatment with antihypertensive effect for at least 3 months
•* previously diagnosed but without treatment with antihypertensive effect for at least 3 months
•4. Patients follow-up within the scope of the current medical practice and in the same health centre during the 6-month period

Exclusion Criteria

•1. Previously attended to the Ngay Dau Tien educational program for HBP management
•2. Plan to be hospitalized for other medical conditions during the next 6 months
•3. Plan to move/relocate during 6-month follow-up
•4. Have a severe disease (i.e. cirrhosis, end-stage renal disease …)
•5. Are unlikely to cooperate in the study
•6. Arm 1: patient having contra-indication to take Viacoram® according to SmPC
•7. Arm 2: patient showing interest in attending NDT educational program.

Locations (1)

Servier Affaires Médicales

Suresnes, France

Key Dates

Start Date

January 31, 2023

Primary Completion Date

June 12, 2024

Completion Date

June 12, 2024

Last Updated

November 26, 2024

Enrollment

400

ACTUAL participants

Conditions

Hypertension

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITINGPHASE2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820

Pulmonary Hypertension

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 26, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets